Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
35.47
+1.34 (3.93%)
Jun 26, 2026, 4:00 PM EDT - Market closed
HRMY Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 899.11 | 868.45 | 714.73 | 582.02 | 437.86 | 305.44 | |
Revenue Growth (YoY) | 20.71% | 21.51% | 22.80% | 32.93% | 43.35% | 91.21% |
Cost of Revenue | 210.86 | 198.34 | 156.82 | 121.24 | 83.48 | 55.52 |
Gross Profit | 688.25 | 670.11 | 557.92 | 460.79 | 354.37 | 249.92 |
Selling, General & Admin | 274.3 | 272.05 | 221.27 | 192.69 | 163.3 | 132.03 |
Research & Development | 224.44 | 189.59 | 145.83 | 76.06 | 70.89 | 30.37 |
Total Operating Expenses | 498.73 | 461.64 | 367.09 | 268.76 | 234.19 | 162.39 |
Operating Income | 189.52 | 208.47 | 190.83 | 192.03 | 120.19 | 87.53 |
Interest Income | 22.64 | 21.92 | 18.54 | 14.73 | 3.13 | 0.22 |
Interest Expense | -14.05 | -14.65 | -17.5 | -23.76 | -18.8 | -24.19 |
Other Non-Operating Income (Expense) | -0.53 | -0.68 | -0.07 | -9.61 | 0.17 | -26.15 |
Total Non-Operating Income (Expense) | 8.06 | 6.6 | 0.98 | -18.63 | -15.5 | -50.12 |
Pretax Income | 197.57 | 215.06 | 191.8 | 173.4 | 104.69 | 37.43 |
Provision for Income Taxes | 51.96 | 56.38 | 46.31 | 44.54 | -76.78 | 2.83 |
Net Income | 145.62 | 158.69 | 145.49 | 128.85 | 181.47 | 34.6 |
Net Income to Common | 145.62 | 158.69 | 145.49 | 128.85 | 181.47 | 34.6 |
Net Income Growth | -4.65% | 9.07% | 12.91% | -28.99% | 424.52% | - |
Shares Outstanding (Basic) | 58 | 57 | 57 | 59 | 59 | 58 |
Shares Outstanding (Diluted) | 59 | 59 | 58 | 60 | 61 | 59 |
Shares Change (YoY) | 0.96% | 1.17% | -4.15% | -1.19% | 3.19% | 119.09% |
EPS (Basic) | 2.52 | 2.76 | 2.56 | 2.17 | 3.07 | 0.60 |
EPS (Diluted) | 2.48 | 2.71 | 2.51 | 2.13 | 2.97 | 0.58 |
EPS Growth | -5.34% | 7.97% | 17.84% | -28.28% | 412.07% | - |
Free Cash Flow | 341.79 | 347.89 | 218.67 | 219.08 | 144.29 | 98.26 |
Free Cash Flow Growth | -1.75% | 59.09% | -0.19% | 51.82% | 46.85% | - |
Free Cash Flow Per Share | 5.83 | 5.94 | 3.78 | 3.63 | 2.36 | 1.66 |
Gross Margin | 76.55% | 77.16% | 78.06% | 79.17% | 80.93% | 81.82% |
Operating Margin | 21.08% | 24.00% | 26.70% | 32.99% | 27.45% | 28.66% |
Profit Margin | 16.20% | 18.27% | 20.36% | 22.14% | 41.44% | 11.33% |
FCF Margin | 38.01% | 40.06% | 30.59% | 37.64% | 32.95% | 32.17% |
EBITDA | 214.85 | 233.8 | 214.94 | 216.39 | 143.57 | 106.37 |
EBITDA Margin | 23.90% | 26.92% | 30.07% | 37.18% | 32.79% | 34.82% |
EBIT | 189.52 | 208.47 | 190.83 | 192.03 | 120.19 | 87.53 |
EBIT Margin | 21.08% | 24.00% | 26.70% | 32.99% | 27.45% | 28.66% |
Effective Tax Rate | 26.30% | 26.21% | 24.14% | 25.69% | -73.35% | 7.56% |